| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 523.10M | 307.75M | 173.98M | 159.24M | 142.41M | 93.58M |
| Gross Profit | 72.73M | 48.93M | 30.18M | 39.19M | 34.76M | 24.90M |
| EBITDA | 39.46M | 17.51M | 11.29M | 5.17M | 12.38M | 23.73M |
| Net Income | 26.25M | 11.17M | 2.55M | -6.68M | 19.56M | 16.25M |
Balance Sheet | ||||||
| Total Assets | 448.53M | 422.21M | 377.37M | 350.58M | 365.22M | 330.70M |
| Cash, Cash Equivalents and Short-Term Investments | 35.49M | 32.38M | 37.61M | 30.86M | 31.09M | 32.26M |
| Total Debt | 59.09M | 69.17M | 78.17M | 49.10M | 42.61M | 20.50M |
| Total Liabilities | 163.63M | 161.70M | 125.36M | 94.83M | 81.69M | 80.09M |
| Stockholders Equity | 255.65M | 234.77M | 228.43M | 230.85M | 253.06M | 228.00M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.56M | -27.17M | -10.38M | -28.46M | -9.23M |
| Operating Cash Flow | 0.00 | 11.29M | -16.06M | 5.63M | -10.91M | 4.03M |
| Investing Cash Flow | 0.00 | -9.27M | -7.14M | -15.64M | -9.84M | -10.87M |
| Financing Cash Flow | 0.00 | -7.07M | 30.23M | 10.38M | 19.36M | 249.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$757.29M | 10.67 | 9.75% | 7.55% | -24.96% | -26.43% | |
69 Neutral | $1.79B | 8.77 | 10.89% | ― | 161.65% | 951.04% | |
63 Neutral | HK$525.14M | 23.57 | 1.87% | 8.33% | -1.99% | -81.52% | |
55 Neutral | HK$500.67M | 70.63 | 0.55% | 6.74% | -4.92% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | HK$610.24M | ― | -40.38% | ― | -43.46% | -96.48% |
Chia Tai Enterprises International Limited announced an expected significant increase in its unaudited consolidated profit for the first nine months of 2025, reaching approximately US$23.5 million compared to US$4.3 million in the same period of 2024. This growth is attributed to a successful strategy to boost sales to key customers. However, the company also reported a decline in quarterly profit due to reduced demand for animal health products amid a slowdown in China’s animal farming sector.
The most recent analyst rating on (HK:3839) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Chia Tai Enterprises International stock, see the HK:3839 Stock Forecast page.
Chia Tai Enterprises International Limited has announced its unaudited consolidated results for the six months ending June 30, 2025. The company reported a significant increase in revenue, reaching US$323.3 million compared to US$108 million in the same period last year. The gross profit also rose to US$41.8 million from US$18 million. The profit attributable to shareholders increased to US$17 million from US$2 million, reflecting a substantial improvement in financial performance. The total comprehensive income for the period was US$24.4 million, a notable turnaround from a loss in the previous year.
Chia Tai Enterprises International Limited has announced a board meeting scheduled for August 11, 2025, to approve the interim results for the first half of the year ending June 30, 2025. The meeting will also consider the payment of an interim dividend, which could have implications for the company’s financial strategy and shareholder returns.